CLEO VALDEZ: Open Payments
NPI 1831586098 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,819 in 119 payments from 34 companies in 2025. Trend: 2023 $2,290 · 2024 $2,303 · 2025 $2,819
Food & beverage: $2,819
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $279 |
| Janssen Scientific Affairs, LLC | 2 | $228 |
| BeOne Medicines USA, Inc. | 13 | $200 |
| Novartis Pharmaceuticals Corporation | 7 | $170 |
| Daiichi Sankyo Inc. | 6 | $167 |
| Janssen Biotech, Inc. | 8 | $165 |
| AstraZeneca Pharmaceuticals LP | 8 | $160 |
| E.R. Squibb & Sons, L.L.C. | 7 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $119 |
| ABBVIE INC. | 5 | $111 |
Products named: KEYTRUDA, RYBREVANT, BRUKINSA, ERLEADA, OPDIVO, ENHERTU, PLUVICTO, TEVIMBRA.
Industry payments across AL — which companies pay providers there.
